Author

Fátima Postigo-Corrales

Universidad Católica de MurciaORCID 0000-0002-9457-5088Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Organism:human· 3 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:proteomics· 1

Frequent Co-Authors

Ginés Luengo‐GiliD· 3 shared Ana Belén Arroyo-Rodríguez· 2 shared Begoña Alburquerque-GonzáleziD· 2 shared Diogo Ribeiro· 2 shared Horacio Pérez‐SáncheziD· 2 shared Irene LuqueiD· 2 shared Lucía Giraldo-Ruiz· 2 shared Pablo Conesa‐ZamoraiD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Ginés Luengo‐GilORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCancer Cell InternationalPeer-reviewedSep 22, 2026

Characterizing Compounds Targeting Colorectal Cancer Derived From Monastrol Using High-Through Screening of an Extensive Combinatorial Library

Alejandro Rodríguez-Martínez, Lucía Giraldo-Ruiz, Maria C. Ramos…·Horacio Pérez‐Sánchez

This paper identifies two fascin-binding compounds using a virtual screening approach combined with experimental validation, showing they inhibit CRC cell proliferation and migration.

DOI 10.1186/s12935-026-04467-0

humanproteomics

𝕏 PostBluesky

Cancer BiologyCancer ResearchPeer-reviewedFeb 11, 2026

Discovery and evaluation of novel biomarkers reveal dasatinib as a potential treatment for a specific subtype of Triple-Negative Breast Cancer

Daniel Ortega-Álvarez, David Tébar-García, Marta Casado-Peláez…·Verónica Rodilla

This study identifies BC-markers in TNBC, links them to poor prognosis and dasatinib sensitivity, suggesting TAGLN as a predictive biomarker for targeted therapy.

5 citationstop 2%

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologyScientific ReportsPeer-reviewedApr 28, 2025

Discovery of Z1362873773: A Novel Fascin Inhibitor from a Large Chemical Library for Colorectal Cancer

Alejandro Rodríguez Martínez, Lucía Giraldo-Ruiz, María C. Ramos…·Horacio Pérez‐Sánchez

The paper identifies a novel fascin inhibitor, Z1362873773, from a chemical library that inhibits cancer cell migration and shows potential as a colorectal cancer treatment.

5 citations

humanexperimental assay

𝕏 PostBluesky